Avidity Biosciences Inc’s recent filing unveils that its Chief Financial Officer MacLean Michael F unloaded Company’s shares for reported $4.84 million on Nov 06 ’24. In the deal valued at $45.56 per share,106,319 shares were sold. As a result of this transaction, MacLean Michael F now holds 94,093 shares worth roughly $3.97 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, MICHAEL MACLEAN bought 106,319 shares, generating $4,793,924 in total proceeds.
Before that, LEVIN ARTHUR A sold 5,000 shares. Avidity Biosciences Inc shares valued at $233,168 were divested by the Director at a price of $46.63 per share. As a result of the transaction, LEVIN ARTHUR A now holds 14,830 shares, worth roughly $0.63 million.
Goldman initiated its Avidity Biosciences Inc [RNA] rating to a Buy in a research note published on September 24, 2024; the price target was $59. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in late August with a ‘”an Overweight”‘ rating. BofA Securities began covering RNA with “Buy” recommendation on May 03, 2024. Cantor Fitzgerald started covering the stock on March 14, 2024. It rated RNA as “an Overweight”.
Price Performance Review of RNA
On Friday, Avidity Biosciences Inc [NASDAQ:RNA] saw its stock fall -15.59% to $42.18. Over the last five days, the stock has lost -9.72%. Avidity Biosciences Inc shares have risen nearly 366.08% since the year began. Nevertheless, the stocks have risen 577.05% over the past one year. While a 52-week high of $56.00 was reached on 11/13/24, a 52-week low of $5.68 was recorded on 01/02/24. SMA at 50 days reached $45.26, while 200 days put it at $34.39.
Levels Of Support And Resistance For RNA Stock
The 24-hour chart illustrates a support level at 39.24, which if violated will result in even more drops to 36.30. On the upside, there is a resistance level at 47.72. A further resistance level may holdings at 53.26. The Relative Strength Index (RSI) on the 14-day chart is 42.17, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.37, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bearish at 92.88%. Stochastics %K at 47.69% indicates the stock is a holding.
How much short interest is there in Avidity Biosciences Inc?
A steep rise in short interest was recorded in Avidity Biosciences Inc stocks on 2024-10-31, dropping by -0.11 million shares to a total of 14.66 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 14.77 million shares. There was a decline of -0.78%, which implies that there is a negative sentiment for the stock.
